None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All healthy infants of age group 9-11 weeks brought for immunization with 2nd dose of Liquid Pentavalent Vaccine
Exclusion criteria
Exclusion criteria: 1) Infants with any painful lesion or condition 2) Infants receiving treatment with methaemoglobin-inducing agents 3) Infants on medications which can alter pain perception and response 4) Neurologically depressed infants due to any condition 5) Severe allergic reaction to a vaccine component or following a prior dose of a vaccine 6) History of reaction following application of topical anaesthetic agent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the pain reduction efficacy of the topical local anaesthetic spray with vapocoolant and EMLA cream during vaccination to childrenTimepoint: 0 minute, 1 minute and 5 minutes after injection | — |
Secondary
| Measure | Time frame |
|---|---|
| Not ApplicableTimepoint: Not Applicable | — |
Countries
India
Contacts
JAWAHARLAL NEHRU MEDICAL COLLEGE, KLE ACADEMY OF HIGHER EDUCATION AND RESEARCH